Michael Pavlides (@mikepavlides_1) 's Twitter Profile
Michael Pavlides

@mikepavlides_1

ID: 324098139

calendar_today26-06-2011 00:38:04

189 Tweet

141 Followers

357 Following

Michael Pavlides (@mikepavlides_1) 's Twitter Profile Photo

Delighted to see our paper out in The Lancet Gastroenterology & Hepatology. It would not have been possible without collaboration of the authors of primary studies and LITMUS_Project support. Special mention to Patrick Bossuyt and Ferenc Mozes for methodological innovation and Quentin M. Anstee for inspiration.

Quentin M. Anstee (@qanstee) 's Twitter Profile Photo

πŸ“£Calling all attendees EASLnews #ILC2023!! Please spread the word 😊 ➑️ Two great opportunities for enthusiastic scientists πŸ‘©β€πŸ”¬πŸ§‘β€πŸ”¬πŸ‘¨πŸ½β€πŸ”¬ to join the Newcastle University Liver Research Group. ➑️ Exciting new project on #NASH #NAFLD #Cirrhosis πŸ”¬πŸ§ͺ🧬 jobs.ncl.ac.uk/job/Research-A…

Michael Pavlides (@mikepavlides_1) 's Twitter Profile Photo

All cause mortality was part of the composite end point, so deaths from CV events or non primary liver cancer were captured. However, numbers and follow-up not large / long enough to draw conclusions for individual types of events.

Dimitris Koutoukidis (@dkoutoukidis) 's Twitter Profile Photo

Very excited our trial is out showing the safety and potential efficacy of rapid weight loss in #NASH. dx.doi.org/10.1002/oby.23…

George Ioannou (@gnioannou) 's Twitter Profile Photo

In this meta-analysis of individual patient data, liver biopsy performed the same as FIB-4, fibroscan liver stiffness and NAFLD fibrosis score in predicting clinical outcomes up to 10 yrs in pts with NAFLD Time to abandon liver biopsies! ➑ Use FIB-4! doi.org/10.1016/S2468-…

In this meta-analysis of individual patient data, liver biopsy performed the same as FIB-4, fibroscan liver stiffness and NAFLD fibrosis score in predicting clinical outcomes up to 10 yrs in pts with NAFLD

Time to abandon liver biopsies!
➑ Use FIB-4!

doi.org/10.1016/S2468-…
Gut Journal (@gut_bmj) 's Twitter Profile Photo

#GUTPodcast with Tom Marjot on "Timing of energy intake and the therapeutic potential of intermittent fasting and time-restricted eating in NAFLD" via apple.co/3rOFXv3, spoti.fi/3DDaqPn or bit.ly/3rScAIf Paper: bit.ly/3JWrMu0 OCDEM NIHR Oxford Biomedical Research Centre

#GUTPodcast with <a href="/tom_marjot/">Tom Marjot</a> on 

"Timing of energy intake and the therapeutic potential of intermittent fasting and time-restricted eating in NAFLD" via apple.co/3rOFXv3, spoti.fi/3DDaqPn or bit.ly/3rScAIf

Paper: bit.ly/3JWrMu0

<a href="/OCDEM/">OCDEM</a> <a href="/OxfordBRC/">NIHR Oxford Biomedical Research Centre</a>
DeLIVER-HCC (@deliver_hcc) 's Twitter Profile Photo

🚨 UPDATE 🚨 We reached 80 patients enrolled in the SELINA study! πŸ₯³ Things are picking up! πŸ₯³ Thank you so much to our team at the Southampton site for their amazing work so far and for recruiting patient 80th! Ellie Barnes πŸš΅β€β™€οΈ Cancer Research UK @NIHRCRN_tvsm University Hospital Southampton πŸ’™

Tamsin Cargill (@tamcarg) 's Twitter Profile Photo

⁦⁦HBV001 phase 1 clinical trail of therapeutic vaccine ChAdOx1-HBV in healthy volunteers and patients with #HBV published in ⁦JHEP Reports⁩ ⁦Ellie Barnes πŸš΅β€β™€οΈβ© jhep-reports.eu/article/S2589-…

LITMUS_Project (@litmus_imi) 's Twitter Profile Photo

After 6+ years, the LITMUS_Project project will be ending in a few months. The final General Assembly has just been held in Copenhagen. Among the highlights was the news that we have successfully submitted the initial Qualification Package to the Food and Drug Administration (FDA).

After 6+ years, the <a href="/LITMUS_IMI/">LITMUS_Project</a> project will be ending in a few months. The final General Assembly has just been held in Copenhagen. Among the highlights was the news that we have successfully submitted the initial Qualification Package to the Food and Drug Administration (FDA).
LITMUS_Project (@litmus_imi) 's Twitter Profile Photo

This comprehensive submission includes PRO-C3, ADAPT, and the FAST score, with the context of use 'Diagnostic Enrichment'. Such an achievement stands as a testament to the collective endeavours of the entire LITMUS consortium. Innovative Health Initiative EFPIA

LITMUS_Project (@litmus_imi) 's Twitter Profile Photo

The goal of LITMUS is to develop & validate highly accurate blood tests and imaging techniques to allow doctors & researchers to rapidly and easily diagnose the severity of disease and monitor changes in patients’ livers for Metabolic dysfunction-associated steatohepatitis (MASH)

Ellie Barnes πŸš΅β€β™€οΈ (@eleanorbarnesox) 's Twitter Profile Photo

@HcvFlavi2024 I am delighted to be organising the 30th International Symposium on Hepatitis C Virus, Flaviviruses, and Related Viruses in September in University of Oxford this year. Do sign up - it is going to be AMAZING!!!

Tom Marjot (@tom_marjot) 's Twitter Profile Photo

1/ This week I saw a 66-year-old lady with ALD cirrhosis who had turned her life around with 3-yrs of abstinence. However, she drank 4 bottles of 0% beer/day. This felt like a red flag but I had to go away and look at the data. 🧡Here's a #tweetorial about what I learnt...

1/ This week I saw a 66-year-old lady with ALD cirrhosis who had turned her life around with 3-yrs of abstinence.

However, she drank 4 bottles of 0% beer/day. This felt like a red flag but I had to go away and look at the data. 

🧡Here's a #tweetorial about what I learnt...
Shivan Sivakumar (@shivansivakumar) 's Twitter Profile Photo

Myself and other top oncologists interviewed in the Guardian on what we do to reduce our risk of cancer. It is a really nice article to read. It is doing the simple things that count! Uni of Birmingham Immunology and Immunotherapy University Hospitals Birmingham theguardian.com/lifeandstyle/a…